Changes in the pharmacokinetics of digoxin in polyuria in streptozotocin-induced diabetic mice and lithium carbonate-treated mice

References

• Abad-Santos F, Carcas AJ, Ibáñez C, Frías J. (2000). Digoxin level and clinical manifestations as determinants in the diagnosis of digoxin toxicity. Ther Drug Monit 22:163–168.
   PubMed Web of Science ®Google Scholar
• Agha A, Smith D, Finucane F, Sherlock M, Morris A, Baylis P, Thompson CJ. (2004). Attenuation of vasopressin-induced antidiuresis in poorly controlled type 2 diabetes. Am J Physiol Endocrinol Metab 287:E1100–E1106.
   Google Scholar
• Baumgarten R, Van De Pol MH, Wetzels JF, Van Os CH, Deen PM. (1998). Glycosylation is not essential for vasopressin-dependent routing of aquaporin-2 in transfected Madin-Darby canine kidney cells. J Am Soc Nephrol 9:1553–1559.
   PubMedGoogle Scholar
• Bedford JJ, Leader JP, Jing R, Walker LJ, Klein JD, Sands JM, Walker RJ. (2008). Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 294:F812–F820.
   Google Scholar
• Forrest JN Jr, Cohen AD, Torretti J, Himmelhoch JM, Epstein FH. (1974). On the mechanism of lithium-induced diabetes insipidus in man and the rat. J Clin Invest 53:1115–1123.
   PubMed Web of Science ®Google Scholar
• Hendriks G, Koudijs M, van Balkom BW, Oorschot V, Klumperman J, Deen PM, van der Sluijs P. (2004). Glycosylation is important for cell surface expression of the water channel aquaporin-2 but is not essential for tetramerization in the endoplasmic reticulum. J Biol Chem 279:2975–2983.
   PubMedGoogle Scholar
• Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U. (2000). Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97:3473–3478.
   PubMed Web of Science ®Google Scholar
• Ito K, Takasaki A, Ikarashi N, Watanabe J, Kanitani M, Sugiyama K. (2009). Effects of Kampo medicines on Cyp3a and P-glycoprotein activity in vivo. J Trad Med 26, 131–135.
   Google Scholar
• Kauker ML. (1981). Digoxin transport in the distal nephron of rats during saline diuresis. Proc Soc Exp Biol Med 168:5–9.
   PubMedGoogle Scholar
• Kawaguchi H, Matsui Y, Watanabe Y, Takakura Y. (2004). Effect of interferon-gamma on the pharmacokinetics of digoxin, a P-glycoprotein substrate, intravenously injected into the mouse. J Pharmacol Exp Ther 308:91–96.
   PubMed Web of Science ®Google Scholar
• Kawahara M, Sakata A, Miyashita T, Tamai I, Tsuji A. (1999). Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice. J Pharm Sci 88:1281–1287.
   PubMed Web of Science ®Google Scholar
• Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19.
   PubMed Web of Science ®Google Scholar
• Koren G, Klein J, Bentur Y, Giesbrecht E. (1989). The effects of mannitol diuresis on digoxin and phenobarbital handling by the kidney: implications for tubular reabsorption and secretion of the cardiac glycoside. Clin Invest Med 12:279–284.
   PubMedGoogle Scholar
• Kudo T, Toda T, Ushiki T, Ohi K, Ikarashi N, Ochiai W, Sugiyama K. (2010). Differences in the pharmacokinetics of Cyp3a substrates in TSOD and streptozotocin-induced diabetic mice. Xenobiotica 40:282–290.
   PubMed Web of Science ®Google Scholar
• Kwon TH, Laursen UH, Marples D, Maunsbach AB, Knepper MA, Frokiaer J, Nielsen S. (2000). Altered expression of renal AQPs and Na(+) transporters in rats with lithium-induced NDI. Am J Physiol Renal Physiol 279:F552–F564.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• Mahdyoon H, Battilana G, Rosman H, Goldstein S, Gheorghiade M. (1990). The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. Am Heart J 120:1189–1194.
   PubMed Web of Science ®Google Scholar
• Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. (1995). Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 95:1838–1845.
   PubMed Web of Science ®Google Scholar
• Marples D, Knepper MA, Christensen EI, Nielsen S. (1995). Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J Physiol 269:C655–C664.
   PubMed Web of Science ®Google Scholar
• Mooradian AD. (1988). Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations. Clin Pharmacokinet 15:165–179.
   PubMed Web of Science ®Google Scholar
• Movig KL, Baumgarten R, Leufkens HG, van Laarhoven JH, Egberts AC. (2003). Risk factors for the development of lithium-induced polyuria. Br J Psychiatry 182:319–323.
   PubMedGoogle Scholar
• Salphati L, Benet LZ. (1999). Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A. Xenobiotica 29:171–185.
   PubMed Web of Science ®Google Scholar
• Satake M, Ikarashi N, Ichikawa Y, Maniwa A, Toda T, Ito K, Ochiai W, Sugiyama K. (2010). The role of renal aquaporin 2 in the alleviation of dehydration associated with diabetic polyuria in KKAy mice. Life Sci 87:475–480.
   PubMedGoogle Scholar
• Satake M, Ikarashi N, Kagami M, Ogiue N, Toda T, Kobayashi Y, Ochiai W, Sugiyama K. (2010). Increases in the expression levels of aquaporin-2 and aquaporin-3 in the renal collecting tubules alleviate dehydration associated with polyuria in diabetes mellitus. Biol Pharm Bull 33:1965–1970.
   PubMedGoogle Scholar
• Spira A, Gowrishankar M, Halperin ML. (1997). Factors contributing to the degree of polyuria in a patient with poorly controlled diabetes mellitus. Am J Kidney Dis 30:829–835.
   PubMed Web of Science ®Google Scholar
• Steiness E, Waldorff S, Hansen PB. (1982). Renal digoxin clearance: dependence on plasma digoxin and diuresis. Eur J Clin Pharmacol 23:151–154.
   PubMedGoogle Scholar
• Stockelman MG, Lorenz JN, Smith FN, Boivin GP, Sahota A, Tischfield JA, Stambrook PJ. (1998). Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. Am J Physiol 275:F154–F163.
   Web of Science ®Google Scholar
• Sugitani M, Abe R, Ikarashi N, Ito K, Muratake H, Shudo K, Sugiyama K. (2009). Disposition of a new tamibarotene prodrug in mice. Biol Pharm Bull 32:1997–2001.
   PubMed Web of Science ®Google Scholar
• Thomsen K, Shirley DG. (2006). A hypothesis linking sodium and lithium reabsorption in the distal nephron. Nephrol Dial Transplant 21:869–880.
   PubMed Web of Science ®Google Scholar
• Umenishi F, Narikiyo T, Schrier RW. (2005). Effect on stability, degradation, expression, and targeting of aquaporin-2 water channel by hyperosmolality in renal epithelial cells. Biochem Biophys Res Commun 338:1593–1599.
   PubMed Web of Science ®Google Scholar
• Watkins JB 3rd, Sherman SE. (1992). Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin. J Pharmacol Exp Ther 260:1337–1343.
   PubMedGoogle Scholar
• Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lépine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK. (1996). Cross-national epidemiology of major depression and bipolar disorder. JAMA 276:293–299.
   PubMed Web of Science ®Google Scholar
• Yamaki M, Kusano E, Tetsuka T, Takeda S, Homma S, Murayama N, Asano Y. (1991). Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats. Am J Physiol 261:F505–F511.
   PubMedGoogle Scholar